Navigation Links
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
Date:11/2/2009

ing cause of cirrhosis and liver cancer, and the number one reason for liver transplants in the United States and Europe.

About PEGINTRON

PEGINTRON is indicated for use in combination with REBETOL (ribavirin) for the treatment of chronic hepatitis C in patients 3 years of age and older with compensated liver disease.

The following points should be considered when initiating therapy with PEGINTRON in combination with REBETOL:

(1) These indications are based on achieving undetectable HCV RNA after treatment for 24 or 48 weeks and maintaining a Sustained Virologic Response (SVR) 24 weeks after the last dose.

(2) Patients with the following characteristics are less likely to benefit from re-treatment after failing a course of therapy: previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and genotype 1 infection.

(3) No safety and efficacy data are available for treatment of longer than one year.

PEGINTRON is also indicated for use alone for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with interferon alpha and who are at least 18 years of age.

The following points should be considered when initiating therapy with PEGINTRON alone: Combination therapy with REBETOL is preferred over PEGINTRON monotherapy unless there are contraindications to, or significant intolerance of, REBETOL. Combination therapy provides substantially better response rates than monotherapy.

Important Safety Information on PEGINTRON

WARNING: RISK OF SERIOUS DISORDERS AND RIBAVIRIN-ASSOCIATED EFFECTS

Alpha interferons, including PEGINTRON, may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Patients with persistently
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 2014 The medical magnetic resonance imaging ... 4%, with world market revenues for 2013 at ... other types of medical imaging have led to ... medical conditions in children and adults, each imaging ... Medical Imaging Markets , analyzes the current ...
(Date:11/26/2014)... , November 25, 2014 ... Market by Power Source (Electric, Battery, Pneumatic), by ... Blade, Burr, Cart), by Application (Orthopedic, ENT, Oral, ... by MarketsandMarkets, the global Powered Surgical Instruments Market is ... Billion in 2014 and is expected to grow ...
(Date:11/26/2014)... , Nov. 25, 2014  goBalto, Inc., the leading ... recognized as a winner of Red Herring,s Top ... Top 100 North America award in 2013, marking its ... landscape. Red Herring,s Top 100 Global list ... new companies and entrepreneurs. Red Herring editors were among ...
Breaking Medicine Technology:Kalorama: Steady Growth in the Medical MRI Market 2Kalorama: Steady Growth in the Medical MRI Market 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3
... Codexis, Inc. (Nasdaq: CDXS ) today announced the ... Technology Leadership Forum, to be held in Vail, CO on ... Financial Officer, will appear on a panel titled "Crude Alternatives: ... 8 at 12:30 p.m. ET. A webcast is not being ...
... 14, 2011 Neuralstem, Inc. (NYSE Amex: ... notice of allowance for U.S. Patent Applications 12/939,897 ...  The patents cover three new compounds and include ... and the growth of new neurons, both in-vitro ...
Cached Medicine Technology:Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents 2Neuralstem Announces Notice of Allowance for Two Additional Neurogenic Compound Patents 3
(Date:11/26/2014)... CA (PRWEB) November 26, 2014 With ... orthopedic surgeon Dr. Steven Meier has enhanced the ... offer current and prospective patients an online destination for ... really excited to present the new and improved version ... features make it easier than ever for current and ...
(Date:11/26/2014)... 2014 Sonru, the video interviewing specialist, ... Operating Officer and Chief Marketing Officer, in addition to ... , Jeff Jones has been appointed as Chief Operating ... the role of Chief Marketing Officer. , Mr Jones ... 25-year career includes senior roles with The Walt Disney ...
(Date:11/26/2014)... 2014 Medical suction and vacuum products ... 5. This score represents steady growth in the price ... 2014 as a result of swelling demand for healthcare ... are largely considered nondiscretionary. IBISWorld market research analyst, Anna ... some degree of flexibility, given the low level of ...
(Date:11/26/2014)... 2014 News Facts , Lexmark’s ... at RSNA 2014 in Chicago. The company will ... diagnostic images, photos, videos and documents found throughout ... will learn more about these innovative medical content ... partner initiatives – that enable more informed clinical ...
(Date:11/26/2014)... 25, 2014 (HealthDay News) -- Vultures have developed highly ... ingest when eating dead animals, researchers report. The ... on the faces and in the guts of 50 ... On average, the faces of the vultures had more ... in their guts, the study found. The findings ...
Breaking Medicine News(10 mins):Health News:Los Angeles Orthopedic Surgeon Dr. Steven Meier Announces Relaunch Of Practice Website 2Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3
... is lot of controversies over the usage of Generic drugs in ... done a survey to find out that usage of generic drugs ... be more in the future. Though it is well known that ... industries, who would not accept this fact but the reality is ...
... Brompton and Harefield NHS Trust have found Cryosurgery effective ... team has so far operated 16 patients using this ... surgical removal of tumor mass is not possible. It ... diseased lung is not possible due to severe breathing ...
... from persistence of REM activity, including typical paralysis associated// ... become aware or as they are falling asleep. ... surroundings, but are unable to move. Hallucinations, such as ... chest, and hearing footsteps or odd sounds commonly accompany ...
... is considered to be a unifying link between diabetes ... sufficient evidence on increased production of oxidants and decreased ... contributes to oxidative stress. An increase in oxidative stress ... in diabetic patients. ,A new study, which ...
... Cardiovascular diseases have now become common place owing to ... style. Time and over again, scientists have been working ... surgical intervention. The results of a recent research have ... treatment of cardiovascular diseases. ,The leeches have ...
... present in the central nervous system, including// that of ... yet. Altered prionic proteins, pathogens, infectants, i.e. prions, are ... encephalopathy (BSE or mad cow disease). In order to ... the importance of this investigation for the location of ...
Cached Medicine News:Health News:Generic Drugs Usage In US Can Save $20 Billion – Express Script Surve 2Health News:Cryosurgery – Freeze Therapy For Lung Cance 2Health News:Isolated Sleep Paralysis In Patients With Anxiety Disorders 2Health News:Protein Carbonyl Level Causes Oxidative Protein Damage In Diabetics 2Health News:Leeches Provide Clues Regarding The Prevention Of Heart Disease 2Health News:The 'Mad Cow' Disease And Protein 2
... is effective against gram positive and gram ... interfering with bacterial protein synthesis by binding ... suggested working concentration of 50 mg/L is ... thereby making a gentler alternative to penicillin ...
... new approach to practice management, built to address ... healthcare market. OPIE was created by practicing O&P ... in this field, so it thinks the way ... than anything else available. If you believe there ...
... new hand-held Slit Lamp HSL150 with an ... For Human and Veterinary medicine for the ... an ergonomic, compact,design, the new HEINE HSL ... slit lamp is not available,or practical to ...
... used for endophotocoagulation indications, ... uncompromised laser treatment of ... handpieces are compatible with ... (532 nm), OcuLight infrared ...
Medicine Products: